Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedRemoved the government funding/operating status notice banner from the page.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedNo additions or deletions were detected; the Study Details page content appears unchanged.SummaryDifference0.4%

- Check32 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Ovarian cancer, expanding the page's coverage to include genetic information about ovarian cancer.SummaryDifference0.2%

- Check46 days agoChange DetectedAdd: new government funding/status notice and v3.2.0; Remove: old ovarian cancer topic listing and v3.1.0.SummaryDifference3%

- Check53 days agoChange Detected- Added: Revision: v3.1.0. - Removed: a specific resource (Ovarian cancer) under Genetic and Rare Diseases Information Center resources and the older Revision: v3.0.2.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a new MedlinePlus Genetics topic on Ovarian cancer and updated to v3.0.2; removed the 'Back to Top' link.SummaryDifference0.4%

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.